Why Nostr? What is Njump?
2023-11-15 14:26:33
in reply to

Prof. Emily M. Bender(she/her) on Nostr: "And there’s another risk, too: Rules that are too onerous could quash innovation ...

"And there’s another risk, too: Rules that are too onerous could quash innovation that might yield benefits for patients if it can make care better, cheaper and more equitable."

Sorry, but no. So-called "AI" in medical settings is vastly under-regulated.

"might yield benefits" "might be more equitable": It must be on companies to show that they have created something safe and effective BEFORE putting it in front of patients & providers. Period.
Author Public Key
npub1z0kfl4g93gvv6ztazp0adm6rwk0r04v3tvwqrmfk4ncw7k37du4qk0pp3u